STAT Plus: In new document, the Trump administration labors to defend its latest drug pricing proposal
CHIP SOMODEVILLA/GETTY IMAGES
A new Q&A, obtained by STAT, parries several key criticisms — some already aired, some expected — from drug makers and other groups.
No hay comentarios:
Publicar un comentario